![]() |
|
|
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 21. | R. Scott Obach, James G. Baxter, Theodore E. Liston, B. Michael Silber, Barry C. Jones, Fiona Macintyre, David J. Rance, Philip Wastall | ||
| The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data | |||
|---|---|---|---|
|
J. Pharmacol. Exp. Ther. Oct 01, 1997; 283: 46-58.
(In "DRUG METABOLISM AND DISPOSITION") |
|||
| 22. | J. R. Mitchell, D. J. Jollow, W. Z. Potter, J. R. Gillette, B. B. Brodie | ||
| ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE | |||
|
J. Pharmacol. Exp. Ther. Oct 01, 1973; 187: 211-217.
(In "ARTICLES") |
|||
| 23. | Vincent A. Pollack, Douglas M. Savage, Deborah A. Baker, Konstantinos E. Tsaparikos, Donald E. Sloan, James D. Moyer, Elsa G. Barbacci, Leslie R. Pustilnik, Teresa A. Smolarek, John A. Davis, Madhur P. Vaidya, Lee D. Arnold, John L. Doty, Kenneth K. Iwata, Michael J. Morin | ||
| Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice | |||
|
J. Pharmacol. Exp. Ther. Nov 01, 1999; 291: 739-748.
(In "ARTICLES") |
|||
| 24. | Edson X. Albuquerque, Manickavasagom Alkondon, Edna F. R. Pereira, Newton G. Castro, Andre Schrattenholz, Catão T. F. Barbosa, Rafael Bonfante-Cabarcas, Yasco Aracava, Howard M. Eisenberg, Alfred Maelicke | ||
| Properties of Neuronal Nicotinic Acetylcholine Receptors: Pharmacological Characterization and Modulation of Synaptic Function, | |||
|
J. Pharmacol. Exp. Ther. Mar 01, 1997; 280: 1117-1136.
(In "THE 1996 ASPET OTTO KRAYER AWARD LECTURE") |
|||
| 25. | AP Zou, YH Ma, ZH Sui, PR Ortiz de Montellano, JE Clark, BS Masters, RJ Roman | ||
| Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats | |||
|
J. Pharmacol. Exp. Ther. Jan 01, 1994; 268: 474-481.
(In "ARTICLES") |
|||
| 26. | F Dorje, J Wess, G Lambrecht, R Tacke, E Mutschler, MR Brann | ||
| Antagonist binding profiles of five cloned human muscarinic receptor subtypes | |||
|
J. Pharmacol. Exp. Ther. Feb 01, 1991; 256: 727-733.
(In "ARTICLES") |
|||
| 27. | HY Meltzer, S Matsubara, JC Lee | ||
| Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values | |||
|
J. Pharmacol. Exp. Ther. Oct 01, 1989; 251: 238-246.
(In "ARTICLES") |
|||
| 28. | Z Wang, G Ciabattoni, C Creminon, J Lawson, GA Fitzgerald, C Patrono, J Maclouf | ||
| Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man | |||
|
J. Pharmacol. Exp. Ther. Oct 01, 1995; 275: 94-100.
(In "ARTICLES") |
|||
| 29. | H Saito, M Okuda, T Terada, S Sasaki, K Inui | ||
| Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney | |||
|
J. Pharmacol. Exp. Ther. Dec 01, 1995; 275: 1631-1637.
(In "ARTICLES") |
|||
| 30. | MR Siegfried, J Erhardt, T Rider, XL Ma, AM Lefer | ||
| Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion | |||
|
J. Pharmacol. Exp. Ther. Feb 01, 1992; 260: 668-675.
(In "ARTICLES") |
|||
| [Previous 10 Articles] [Next 10 Articles] | |||
= from the current issue
Last Updated: 12/09/2008 15:08:37